Natus Medical Incorporated NTUS
32.96 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
32.84 Day range 33.07
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.32 | 0.32 – 0.32 | 0.29 | +10.3% | 120.40M | +3.8% | 1 |
| Next quarter | 0.37 | 0.37 – 0.37 | 0.28 | +32.1% | 123.70M | +8.6% | 1 |
| Current year | 1.44 | 1.44 – 1.44 | 1.20 | +20.0% | 495.00M | +4.6% | 1 |
| Next year | 1.57 | 1.57 – 1.57 | 1.44 | +9.0% | 517.20M | +4.5% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2, 2017 | Raymond James | Downgrade | Outperform | Market Perform |
| Oct 4, 2016 | Benchmark | Initiated | — | Buy |
| Sep 13, 2016 | Raymond James | Upgrade | Market Perform | Outperform |
| Apr 5, 2016 | Roth Capital | Maintained | — | Buy |
| Oct 7, 2014 | William Blair | Downgrade | Market Perform | Outperform |
| May 6, 2013 | CJS Securities | Initiated | — | Market Perform |
| May 2, 2013 | Raymond James | Upgrade | Market Perform | Outperform |